| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 01/11/2007 | US20070009550 Postweaning multisystemic wasting syndrome and porcine circovirus from pigs |
| 01/11/2007 | US20070009546 Isolated nucleic acid; screening for antibacterial compounds |
| 01/11/2007 | US20070009538 Expression and export of angiogenesis inhibitors as immunofusins |
| 01/11/2007 | US20070009530 Antitumor agents; antiproliferative agents; neurodegenerative diseases; using interfering rna; antagonist hedgehog gene; blocking antibodies |
| 01/11/2007 | US20070009501 Squamous cell carcinoma antigens and use therefor |
| 01/11/2007 | US20070009500 Compositions and methods for the treatment of lysosomal storage disorders |
| 01/11/2007 | US20070009499 Myoblast treatment of diseased or weakened organs |
| 01/11/2007 | US20070009498 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines |
| 01/11/2007 | US20070009497 Dendritic cell expanded T suppressor cells and methods of use thereof |
| 01/11/2007 | US20070009496 Method of growing myocardial cells |
| 01/11/2007 | US20070009489 Mutant Salmonella species with genetically engineered MSBB gene, expresses altered lipid, has reduced inductino of tumor necrosis factor and increased sensitivity to chelating agents; as antitumor agent |
| 01/11/2007 | US20070009488 Feline granulocyte macrophage colony stimulating factor nucleic acid molecules |
| 01/11/2007 | US20070009487 Minimal promoters and uses thereof |
| 01/11/2007 | US20070009486 Adenoviral vectors having a protein IX deletion |
| 01/11/2007 | US20070009485 dextrin polymers in combination with sugars provide enhanced delivery of nucleic acids, particularly eucaryotic expression vectors, demonstrate enhanced delivery of nucleic acids to cells in vivo |
| 01/11/2007 | US20070009484 Compositions and methods involving MDA-7 for the treatment of cancer |
| 01/11/2007 | US20070009483 Compositions and methods for the therapeutic treatment of diabetes |
| 01/11/2007 | US20070009482 Stimulant of immunology response; viricides |
| 01/11/2007 | US20070009481 Use of fak-related non-kinase in the manufacture of a medicament for the inhibition of stenosis and restenosis |
| 01/11/2007 | US20070009468 Photodynamic method of inducing the growth of hair |
| 01/11/2007 | US20070009437 Intracellular trapping of radionuclides by enzyme-mediated reduction |
| 01/11/2007 | US20070009435 Compositions and methods for enhanced delivery to target sites |
| 01/11/2007 | DE60210297T2 Verwendung von langem pentraxin ptx3 für die behandlung von infertilität bei frauen Use of long pentraxin PTX3 for the treatment of infertility in women |
| 01/11/2007 | DE19713543B4 Bakterielle Plasmide Bacterial plasmids |
| 01/11/2007 | CA2614110A1 Compositions and methods for the treatment or prevention of disorders relating to oxidative stress |
| 01/10/2007 | EP1741792A1 Novel ligand of g-protein-conjugated receptor protein and use thereof |
| 01/10/2007 | EP1741789A1 Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines |
| 01/10/2007 | EP1741785A1 Porcine circoviruses, nucleic acids, polypeptides and vaccines |
| 01/10/2007 | EP1741784A1 85kDa neisserial antigen |
| 01/10/2007 | EP1741783A1 Human antiamyloid beta peptide antibody and antibody fragment thereof |
| 01/10/2007 | EP1741782A2 Immunogenic polypeptides encoded by MAGE minigenes and uses thereof |
| 01/10/2007 | EP1741781A2 RNA interference mediated treatment of Alzheimer's disease using short interfering nucleic acid (siNA) |
| 01/10/2007 | EP1741779A2 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine mediated toxicity |
| 01/10/2007 | EP1741777A1 Compositions comprising viruses and methods for concentrating virus preparations |
| 01/10/2007 | EP1741449A1 Preventive and/or remedy for cancer |
| 01/10/2007 | EP1740703A1 Multiple heat shock elements |
| 01/10/2007 | EP1740699A1 Connexin 40 tissue specific gene mutations |
| 01/10/2007 | EP1740603A2 Novel hiv+ infected cells targeting retroviral vectors and uses thereof for treatment of hiv infection |
| 01/10/2007 | EP1740600A1 Intracellular delivery of osteoinductive proteins and peptides |
| 01/10/2007 | EP1740221A2 Methods and compositions for the treatment of polycystic diseases |
| 01/10/2007 | EP1740219A2 Medical device with coating for capturing genetically-altered cells and methods of using same |
| 01/10/2007 | EP1740218A1 Materials for treating vascular leakage in the eye |
| 01/10/2007 | EP1740193A2 Macromolecule-containing sustained release intraocular implants and related methods |
| 01/10/2007 | EP1740167A2 Treatment of type 1 diabetes with inhibitors of macrophage migration inhibitory factor |
| 01/10/2007 | EP1451300A4 Methods and compositions for the use of stromal cells to support embryonic and adult stem cells |
| 01/10/2007 | EP1417227B1 Peptides eefective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/10/2007 | EP1412509B1 Rna amplification system using plant components in animal cells |
| 01/10/2007 | EP1322330B1 Modulation of allergic response |
| 01/10/2007 | EP1078060B1 Antibodies to dendritic cells and human dendritic cell populations and uses thereof |
| 01/10/2007 | EP1017723B1 Costimulating t-cell polypeptide, monoclonal antibodies, their preparation and use |
| 01/10/2007 | EP0949331B1 Established microglia |
| 01/10/2007 | EP0934423B1 Aav-dna helper virus sequences |
| 01/10/2007 | EP0914440B1 Nucleic acid vaccination for parvoviral infections |
| 01/10/2007 | CN1894280A Glycosylation-deficient hepatocyte growth factor |
| 01/10/2007 | CN1894278A Akt activity specifically inhibiting polypeptide |
| 01/10/2007 | CN1893989A Crosslinked hyaluronic acid compositions for tissue augmentation |
| 01/10/2007 | CN1893986A Implant for regenerating bone or cartilage with the use of transcriptional factor |
| 01/10/2007 | CN1893981A Methods and compositions for treatment of interferon-resistant tumors |
| 01/10/2007 | CN1893924A Novel cationic lipopolymer as a biocompatible gene delivery agent |
| 01/10/2007 | CN1893821A 受体 Acceptor |
| 01/10/2007 | CN1891825A Gene and protein relating to hepatocellular carcinoma |
| 01/10/2007 | CN1294269C Adenovirus carrier for specifically killing primary liver cancer cells and its application |
| 01/10/2007 | CN1294268C Recombinant adenovirus vector capable of being duplicated and spread specifically inside tumor cell |
| 01/10/2007 | CN1294143C Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro |
| 01/10/2007 | CN1293922C Application of HGF gene |
| 01/10/2007 | CN1293920C Process for preparing active target-directional carrier mediated by folic acid compound mediated |
| 01/10/2007 | CN1293917C DNA vaccine against proliferating endothelial cells and application thereof |
| 01/09/2007 | US7160990 Immunoglobulin for use in detection and prevention staphylococcus infections |
| 01/09/2007 | US7160985 For therapy of diabetes |
| 01/09/2007 | US7160981 Peptide antagonists of DP transcription factors |
| 01/09/2007 | US7160914 Compounds that exhibit specific molecular recognition of mixed nucleic acid sequences and bind in the DNA minor groove as a dimer |
| 01/09/2007 | US7160869 Biologically active metal-containing nucleic acids |
| 01/09/2007 | US7160868 Nr-CAM gene, nucleic acids and nucleic acid products for therapeutic and diagnostic uses for tumors |
| 01/09/2007 | US7160859 administering compounds/agents that inhibit Mst1 or the Mst1 kinase pathway such as Caspase 3 inhibitors; assay system for screening potential compounds or agents effective to modulate Mst1 activity; transgenic animal wherein Mst1 expression or activity is enhanced |
| 01/09/2007 | US7160727 Transducing a neuron with a transgene from the pseudotyped retrovirus virion; gene therapy for neurodegenerative diseases |
| 01/09/2007 | US7160722 Master bone formation transcription factor: compositions and methods of use |
| 01/09/2007 | US7160720 Nucleotide sequences coding enzymetic polypeptide for use in the treatment of cardiovascular disorders |
| 01/09/2007 | US7160691 Protein fragment complementation assays for the detection of biological or drug interactions |
| 01/09/2007 | US7160541 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 01/09/2007 | US7160539 Altering T cell mediated immunity comprising altering local extracellular concentrations of tryptophan and tryptophan metabolites |
| 01/09/2007 | CA2263129C Mammalian cell surface antigens; related reagents |
| 01/09/2007 | CA2095153C Genetic modification of endothelial cells |
| 01/04/2007 | WO2007002718A2 Rnai modulation of hif-1 and theraputic uses thereof |
| 01/04/2007 | WO2007002663A2 Hierarchically self-assembling linear-dendritic hybrid polymers for delivery of biologically active agents |
| 01/04/2007 | WO2007002512A2 Neuroprotective effective compound |
| 01/04/2007 | WO2007002390A2 Compositions and methods for modulation of smn2 splicing |
| 01/04/2007 | WO2007002373A2 Use of mutant herpes simplex virus-2 for cancer therapy |
| 01/04/2007 | WO2007002285A2 Methods for treating neurological and psychiatric conditions |
| 01/04/2007 | WO2007001962A2 Systems and methods for generating biological material |
| 01/04/2007 | WO2007001943A2 Prefoldin 4 in the treatment and diagnosis of cancer |
| 01/04/2007 | WO2007001684A2 Inhibiting dna polymerase beta to enhance efficacy of anticancer agents |
| 01/04/2007 | WO2007001487A2 Modulation of negative immune regulators and applications for immunotherapy |
| 01/04/2007 | WO2007001430A2 Disimmortalizable mammalian chromaffin cell lines for cell therapy for pain |
| 01/04/2007 | WO2007001010A1 Pharmaceutical for treatment of parkinson’s disease |
| 01/04/2007 | WO2007000935A1 Peptide derived from prostate-related protein as cancer vaccine candidate for prostate cancer patient who is positive for hla-a3 super-type allele molecule |
| 01/04/2007 | WO2007000884A1 Prophylactic/therapeutic agent for bone/joint disease and screening method for the agent |
| 01/04/2007 | WO2006106521A3 Hydrophilic dispersions of nanoparticles of inclusion complexes of macromolecules |
| 01/04/2007 | WO2006058231A3 Viral vectors |
| 01/04/2007 | WO2006009805A3 Combination of a chemotherapeutic agent and an antagonist of a gene product for treating tumors |
| 01/04/2007 | WO2005046450A3 Method for diagnosis and treatment of pulmonary disorders |